Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Conditions
- Estrogen Receptor Negative
- HER2 Positive Breast Carcinoma
- HER2/Neu Negative
- Invasive Breast Carcinoma
- Progesterone Receptor Negative
- Stage I Breast Cancer AJCC v7
- Stage IA Breast Cancer AJCC v7
- Stage IB Breast Cancer AJCC v7
- Stage II Breast Cancer AJCC v6 and v7
- Stage IIA Breast Cancer AJCC v6 and v7
- Stage IIB Breast Cancer AJCC v6 and v7
- Triple-Negative Breast Carcinoma
Interventions
- RADIATION: Undergo EBRT
- OTHER: Laboratory Biomarker Analysis
- OTHER: Quality-of-Life Assessment
- OTHER: Questionnaire Administration
- RADIATION: Partial Breast Irradiation
Sponsor
M.D. Anderson Cancer Center
Collaborators